Immunochina Pharmaceuticals
Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell immunotherapy.
1
Funding Rounds
$20.4m
Money raised
Overview
Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell immunotherapy.
- Website:
- Business model: B2B
- Social accounts: linkedin
Industries
Immunochina Pharmaceuticals is active in the following industries: